-
1
-
-
26944495388
-
Cluster headache: Pathogenesis, diagnosis, and management
-
May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005; 366:843-55.
-
(2005)
Lancet
, vol.366
, pp. 843-855
-
-
May, A.1
-
2
-
-
0025815394
-
Treatment of acute cluster headache with sumatriptan
-
The Sumatriptan Cluster Headache Study Group
-
The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991; 325:322-6.
-
(1991)
N Engl J Med
, vol.325
, pp. 322-326
-
-
-
3
-
-
0027296713
-
Subcutaneous sumatriptan in the acute treatment of cluster headache: A dose comparison study
-
Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand 1993; 88:63-9.
-
(1993)
Acta Neurol Scand
, vol.88
, pp. 63-69
-
-
Ekbom, K.1
Monstad, I.2
Prusinski, A.3
Cole, J.A.4
Pilgrim, A.J.5
Noronha, D.6
-
4
-
-
0028884290
-
Treatment of cluster headache: Clinical trials, design and results
-
Ekbom K. Treatment of cluster headache: clinical trials, design and results. Cephalalgia 1995; 15:33-6.
-
(1995)
Cephalalgia
, vol.15
, pp. 33-36
-
-
Ekbom, K.1
-
6
-
-
0034624925
-
Oral zolmitriptan is effective in the acute treatment of cluster headache
-
Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000; 54:1832-9.
-
(2000)
Neurology
, vol.54
, pp. 1832-1839
-
-
Bahra, A.1
Gawel, M.J.2
Hardebo, J.E.3
Millson, D.4
Breen, S.A.5
Goadsby, P.J.6
-
7
-
-
0036158824
-
Treatment of acute cluster headache with 20 mg sumatriptan nasal spray - an open pilot study
-
Schuh-Hofer S, Reuter U, Kinze S, Einhäupl KM, Arnold G. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray - an open pilot study. J Neurol 2002; 249:94-9.
-
(2002)
J Neurol
, vol.249
, pp. 94-99
-
-
Schuh-Hofer, S.1
Reuter, U.2
Kinze, S.3
Einhäupl, K.M.4
Arnold, G.5
-
8
-
-
0037465448
-
Intranasal sumatriptan in cluster headache: Randomized placebo-controlled double-blind study
-
van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003; 60:630-3.
-
(2003)
Neurology
, vol.60
, pp. 630-633
-
-
van Vliet, J.A.1
Bahra, A.2
Martin, V.3
Ramadan, N.4
Aurora, S.K.5
Mathew, N.T.6
-
9
-
-
0032566160
-
Hypothalamic activation in cluster headache attacks
-
May A, Bahra A, Büchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275-8.
-
(1998)
Lancet
, vol.352
, pp. 275-278
-
-
May, A.1
Bahra, A.2
Büchel, C.3
Frackowiak, R.S.J.4
Goadsby, P.J.5
-
10
-
-
0032489093
-
Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior
-
Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli I, Tanaka H et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-85.
-
(1998)
Cell
, vol.92
, pp. 573-585
-
-
Sakurai, T.1
Amemiya, A.2
Ishii, M.3
Matsuzaki, I.4
Chemelli, I.5
Tanaka, H.6
-
11
-
-
0008390266
-
The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity
-
De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95:322-7.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 322-327
-
-
De Lecea, L.1
Kilduff, T.S.2
Peyron, C.3
Gao, X.4
Foye, P.E.5
Danielson, P.E.6
-
13
-
-
20844433865
-
A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache
-
Rainero I, Gallone S, Valfrè W, Ferrero M, Angilella G, Rivoiro C et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 2005; 63:1286-8.
-
(2005)
Neurology
, vol.63
, pp. 1286-1288
-
-
Rainero, I.1
Gallone, S.2
Valfrè, W.3
Ferrero, M.4
Angilella, G.5
Rivoiro, C.6
-
14
-
-
33745901611
-
Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene
-
Schürks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 2006; 66:1917-9.
-
(2006)
Neurology
, vol.66
, pp. 1917-1919
-
-
Schürks, M.1
Kurth, T.2
Geissler, I.3
Tessmann, G.4
Diener, H.C.5
Rosskopf, D.6
-
15
-
-
33745895274
-
A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort
-
Baumber L, Sjöstrand C, Leone M, Harty H, Bussone G, Hillert J et al. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology 2006; 66:1888-93.
-
(2006)
Neurology
, vol.66
, pp. 1888-1893
-
-
Baumber, L.1
Sjöstrand, C.2
Leone, M.3
Harty, H.4
Bussone, G.5
Hillert, J.6
-
16
-
-
0035061724
-
Orexin-A, an hypothalamic peptide with analgesic properties
-
Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001; 92:81-90.
-
(2001)
Pain
, vol.92
, pp. 81-90
-
-
Bingham, S.1
Davey, P.T.2
Babbs, A.J.3
Irving, E.A.4
Sammons, M.J.5
Wyles, M.6
-
17
-
-
16244381170
-
Orexin-A, an hypothalamic peptide with analgesic properties
-
Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M et al. Orexin-A, an hypothalamic peptide with analgesic properties. Peptides 2005; 26:767-77.
-
(2005)
Peptides
, vol.26
, pp. 767-777
-
-
Mobarakeh, J.I.1
Takahashi, K.2
Sakurada, S.3
Nishino, S.4
Watanabe, H.5
Kato, M.6
-
18
-
-
0346031709
-
Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain
-
Headache Classification Committee of the International Headache Society
-
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalalgia 1988; 8:1-96.
-
(1988)
Cephalalgia
, vol.8
, pp. 1-96
-
-
-
19
-
-
1442265540
-
The International Classification of Headache Disorders
-
Headache Classification Committee of The International Headache Society, 2nd Edn
-
Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders, 2nd Edn. Cephalalgia 2004; 24:1-195.
-
(2004)
Cephalalgia
, vol.24
, pp. 1-195
-
-
-
20
-
-
0034724264
-
Verapamil in the prophylaxis of episodic cluster headache: A double-blind study versus placebo
-
Leone M, D'Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000; 54:1382-5.
-
(2000)
Neurology
, vol.54
, pp. 1382-1385
-
-
Leone, M.1
D'Amico, D.2
Frediani, F.3
Moschiano, F.4
Grazzi, L.5
Attanasio, A.6
-
21
-
-
0035833934
-
Genetic association studies: Genes in search of diseases
-
Bird TD, Jarvik GP, Wood NW. Genetic association studies: genes in search of diseases. Neurology 2001; 57:1153-4.
-
(2001)
Neurology
, vol.57
, pp. 1153-1154
-
-
Bird, T.D.1
Jarvik, G.P.2
Wood, N.W.3
-
22
-
-
2442558400
-
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B activation in the posterior hypothalamic area
-
Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B activation in the posterior hypothalamic area. Pain 2004; 109:367-78.
-
(2004)
Pain
, vol.109
, pp. 367-378
-
-
Bartsch, T.1
Levy, M.J.2
Knight, Y.E.3
Goadsby, P.J.4
-
23
-
-
27744547515
-
Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception
-
Holland PR, Akerman S, Goadsby J. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 2005; 315:1380-5.
-
(2005)
J Pharmacol Exp Ther
, vol.315
, pp. 1380-1385
-
-
Holland, P.R.1
Akerman, S.2
Goadsby, J.3
|